If nothing else, the US Health and Human Services Department’s decision to appeal the recent court decision striking down its direct-to-consumer advertising rule shows how badly the Trump Administration wants to keep swinging in its battle to lower drug prices.
HHS filed a notice of appeal on 21 August, seeking to overturn a lower court ruling that HHS lacks congressional authority under the Social Security Act to require disclosure of list prices in TV commercials for prescription drugs
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?